4 DNA damage response regulates RAG1/2 expression through ATM-FOXO1 | 107 17. Papaemmanuil, E., I. Rapado, Y. Li, N. E. Potter, D. C. Wedge, J. Tubio, L. B. Alexandrov, P. Van Loo, S. L. Cooke, J. Marshall, I. Martincorena, J. Hinton, G. Gundem, F. W. van Delft, S. Nik-Zainal, D. R. Jones, M. Ramakrishna, I. Titley, L. Stebbings, C. Leroy, A. Menzies, J. Gamble, B. Robinson, L. Mudie, K. Raine, S. O’Meara, J. W. Teague, A. P. Butler, G. Cazzaniga, A. Biondi, J. Zuna, H. Kempski, M. Muschen, A. M. Ford, M. R. Stratton, M. Greaves, and P. J. Campbell. 2014. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6RUNX1 acute lymphoblastic leukemia. Nat. Genet. 46: 116–125. 18. Steenbergen, E. J., O. J. Verhagen, E. F. van Leeuwen, A. E. von dem Borne, and C. E. van der Schoot. 1993. Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia. Blood 82: 581–589. 19. Landau, D. A., S. L. Carter, G. Getz, and C. J. Wu. 2014. Clonal evolution in hematological malignancies and therapeutic implications. Leukemia 28: 34–43. 20. Pegoraro, L., L. Matera, J. Ritz, A. Levis, A. Palumbo, and G. Biagini. 1983. Establishment of a Ph1-positive human cell line (BV173). J. Natl. Cancer Inst. 70: 447–453. 21. Muljo, S. A., and M. S. Schlissel. 2003. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Nat. Immunol. 4: 31–37. 22. Barlow, C., S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J. N. Crawley, T. Ried, D. Tagle, and A. Wynshaw-Boris. 1996. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86: 159–171. 23. DiRenzo, J., S. Signoretti, N. Nakamura, R. Rivera-Gonzalez, W. Sellers, M. Loda, and M. Brown. 2002. Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. Cancer Res. 62: 89–98. 24. Weber, K., U. Bartsch, C. Stocking, and B. Fehse. 2008. A multicolor panel of novel lentiviral “gene ontology” (LeGO) vectors for functional gene analysis. Mol. Ther. 16: 698–706. 25. Frecha, C., C. Costa, C. Lévy, D. Nègre, S. J. Russell, A. Maisner, G. Salles, K.-W. Peng, F.-L. Cosset, and E. Verhoeyen. 2009. Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors. Blood 114: 3173–3180. 26. Trancoso, I., M. Bonnet, R. Gardner, J. Carneiro, V. M. Barreto, J. Demengeot, and L. M. Sarmento. 2013. A Novel Quantitative Fluorescent Reporter Assay for RAG Targets and RAG Activity. Front. Immunol. 4: 110. 27. Ochodnicka-Mackovicova, K., M. Bahjat, T. A. Bloedjes, C. Maas, A. M. de Bruin, R. J. Bende, C. J. M. van Noesel, and J. E. J. Guikema. 2015. NF-κB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity. Blood 10: 1324-1335. 28. Hittelman, W. N., and M. Pollard. 1982. Induction and repair of DNA and chromosome damage by neocarzinostatin in quiescent normal human fibroblasts. Cancer Res. 42: 4584–4590. 29. Sadofsky, M. J., J. E. Hesse, J. F. McBlane, and M. Gellert. 1993. Expression and V(D) J recombination activity of mutated RAG-1 proteins. Nucleic Acids Res. 21: 5644–5650. 30. Verkoczy, L., D. Aït-Azzouzene, P. Skog, A. Märtensson, J. Lang, B. Duong, and D. Nemazee. 2005. A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes. Immunity 22: 519–531. 31. Cullen, S. P., and S. J. Martin. 2009. Caspase activation pathways: some recent progress. Cell Death Differ. 16: 935–938. 32. Amin, R. H., and M. S. Schlissel. 2008. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat. Immunol. 9: 613–622.
RkJQdWJsaXNoZXIy MTk4NDMw